Reagentia en instrumenten voor immunologie, celbiologie en moleculaire biologie.
Inloggen
Wachtwoord vergeten?
Open een account
fr
en
es
de
it
pt
nl
0
0
Naar winkelmandje
Catalogus
Onderzoeksgebieden
Diagnostiek
Diensten op maat
CRO services
Technische middelen
Promoties
Contact
Reagentia en instrumenten voor immunologie, celbiologie en moleculaire biologie.
Resultaat van uw zoeken : 9 product gevonden
Verfijn uw zoekopdracht :
RUO
CE / IVD
Conjugate (1)
Unconjugated
8
Reactivity species (1)
human
2
Class (3)
Inhibitor/Antagonist/Agonist
6
Primary antibody
2
Service
1
Host species (1)
mouse
2
Application (3)
IF
2
IHC
2
WB
2
Clone (1)
MGMT/4791
2
BRENG DE FILTERS AAN
INITIALISEREN
DEEL DEZE ZOEKOPDRACHT
GEKOPIEERD
10
20
50
100
200
500
Referentie
Beschrijving
Cond.
Price Bef. VAT
orb1409985-100ug
MGMT (Marker of Suppressor of Mutation and Carcinogenesis) antibody
100ug
orb1409985-20ug
MGMT (Marker of Suppressor of Mutation and Carcinogenesis) antibody
20ug
orb1910729-250mg
Activity of KIN-3248, a next-generation pan-FGFR inhibitor, against acquired FGFR-gatekeeper and molecular-brake drug resistance mutations [[2750709-91-0]]
250mg
orb1910729-1g
Activity of KIN-3248, a next-generation pan-FGFR inhibitor, against acquired FGFR-gatekeeper and molecular-brake drug resistance mutations [[2750709-91-0]]
1g
orb1910729-100mg
Activity of KIN-3248, a next-generation pan-FGFR inhibitor, against acquired FGFR-gatekeeper and molecular-brake drug resistance mutations [[2750709-91-0]]
100mg
orb1910825-1g
MFH290 (MFH-290) is a potent, highly selective, covalent inhibitor of CDK12/13 with IC50 of 25/49 nM.MFH290 forms a covalent bond with Cys-1039 of CDK12, and CDK12-dependent as mutation of Cys-1039 rendered the kinase refractory to MFH290.MFH290 exhibits excellent kinome selectivity, inhibits the phosphorylation of serine-2 in the C-terminal domain (CTD) of RNA-polymerase II (Pol II), and reduces the expression of key DNA damage repair genes.MFH290 restored Pol II CTD phosphorylation and DNA damage repair gene expression AND augments the antiproliferative effect of the PARP inhibitor olaparib. [[2088715-91-5]]
1g
orb1910825-100mg
MFH290 (MFH-290) is a potent, highly selective, covalent inhibitor of CDK12/13 with IC50 of 25/49 nM.MFH290 forms a covalent bond with Cys-1039 of CDK12, and CDK12-dependent as mutation of Cys-1039 rendered the kinase refractory to MFH290.MFH290 exhibits excellent kinome selectivity, inhibits the phosphorylation of serine-2 in the C-terminal domain (CTD) of RNA-polymerase II (Pol II), and reduces the expression of key DNA damage repair genes.MFH290 restored Pol II CTD phosphorylation and DNA damage repair gene expression AND augments the antiproliferative effect of the PARP inhibitor olaparib. [[2088715-91-5]]
100mg
orb1910825-250mg
MFH290 (MFH-290) is a potent, highly selective, covalent inhibitor of CDK12/13 with IC50 of 25/49 nM.MFH290 forms a covalent bond with Cys-1039 of CDK12, and CDK12-dependent as mutation of Cys-1039 rendered the kinase refractory to MFH290.MFH290 exhibits excellent kinome selectivity, inhibits the phosphorylation of serine-2 in the C-terminal domain (CTD) of RNA-polymerase II (Pol II), and reduces the expression of key DNA damage repair genes.MFH290 restored Pol II CTD phosphorylation and DNA damage repair gene expression AND augments the antiproliferative effect of the PARP inhibitor olaparib. [[2088715-91-5]]
250mg
ASC-6012A
CRISPR Custom cell line gene modification; point mutation, samll deletion (<200bp) (normal karyotyping, homozygous); Timeline: 3-5 months
1service
‹
›
